FBIO Q4 2025 Earnings Significant EPS Surprise Miss Amid Limited Revenue Disclosure Addex Therapeutics Q1 2024 Earnings PreRevenue Biotech Advances Pipeline Amid Narrowing Losses FBIOP Q4 2025 Earnings Preferred Stock Reports Negative EPS Surprise Amid No Revenue Disclosure DUK Q1 2026 Earnings EPS Surpasses Estimates as Duke Energy Delivers Steady Operations AMBP Q1 2026 Earnings Strong EPS Beat of 127 Surprise Amid Stock Decline FGBI Q1 2026 Earnings Strong EPS Beat Overshadowed by Modest Stock Decline GBank Financial Holdings Inc GBFH Q1 2026 Earnings Significant EPS Miss as Earnings Fall Short of Expectations LUNR Q1 2026 Earnings EPS Misses Expectations Amid PreRevenue Period Shares Surge 1572 ADAM Q1 2026 Earnings Strong Earnings Beat Drives Stock Up 247 The Oncology Institute Inc TOI Q1 2026 Earnings Narrowing Losses Drive Substantial EPS Beat Arcturus Therapeutics Q1 2026 Earnings Narrower Loss Surprises as Pipeline Progress Continues Heartcore Enterprises Inc HTCR Q2 2025 Earnings Stunning EPS Surprise Highlights Strong Operational Recovery Leidos Q1 2026 Earnings EPS Beat with 586 Surprise Shares Rise